These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38276679)

  • 1. Suboptimal MMR Vaccination Coverages-A Constant Challenge for Measles Elimination in Romania.
    Stanescu A; Ruta SM; Cernescu C; Pistol A
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38276679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward Measles Elimination - Worldwide, 2000-2022.
    Minta AA; Ferrari M; Antoni S; Portnoy A; Sbarra A; Lambert B; Hatcher C; Hsu CH; Ho LL; Steulet C; Gacic-Dobo M; Rota PA; Mulders MN; Bose AS; Caro WP; O'Connor P; Crowcroft NS
    MMWR Morb Mortal Wkly Rep; 2023 Nov; 72(46):1262-1268. PubMed ID: 37971951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-Up Efforts for Serbia.
    Burgess C; Lisul B; Pawaskar M; Petigara T; Murtagh J; Kanazir M; Loncarevic G; Carias C
    Pediatr Infect Dis J; 2024 Aug; ():. PubMed ID: 39105529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.
    Gambrell A; Sundaram M; Bednarczyk RA
    Vaccine; 2022 Jul; 40(32):4574-4579. PubMed ID: 35728989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015.
    Kriss JL; Stanescu A; Pistol A; Butu C; Goodson JL
    Risk Anal; 2017 Jun; 37(6):1096-1107. PubMed ID: 27439071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia.
    Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B
    Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling vaccination coverage during the 2022 central Ohio measles outbreak: a cross-sectional study.
    Martoma RA; Washam M; Martoma JC; Cori A; Majumder MS
    Lancet Reg Health Am; 2023 Jul; 23():100533. PubMed ID: 37497395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coronavirus pandemic on expanded program on immunization in weija gbawe municipality (Accra-Ghana).
    Kissi J; Owusu-Marfo J; Osei E; Dzamvivie K; Akorfa Anku V; Naa Lamiokor Lamptey J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129830. PubMed ID: 36194867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk.
    Mokdad AH; Gagnier MC; Colson KE; Dansereau E; Zúñiga-Brenes P; Ríos-Zertuche D; Haakenstad A; Johanns CK; Palmisano EB; Hernandez B; Iriarte E
    PLoS One; 2015; 10(10):e0139680. PubMed ID: 26506563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal gaps in measles vaccination coverage in Madagascar.
    Mensah K; Heraud JM; Takahashi S; Winter AK; Metcalf CJE; Wesolowski A
    Vaccine; 2019 Apr; 37(18):2511-2519. PubMed ID: 30940486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles vaccine coverage and series completion among children 0-8 years of age in Tianjin, China.
    Montgomery JP; Zhang Y; Carlson B; Ewing S; Wang X; Boulton ML
    Pediatr Infect Dis J; 2015 Mar; 34(3):289-95. PubMed ID: 25259932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the measles epidemic in children from Central Eastern Europe in the third millennium.
    Davitoiu AM; Spatariu L; Plesca DA; Dimitriu M; Cirstoveanu CG; Chindris S
    Exp Ther Med; 2021 Aug; 22(2):816. PubMed ID: 34131439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.
    Torner N; Anton A; Barrabeig I; Lafuente S; Parron I; Arias C; Camps N; Costa J; Martínez A; Torra R; Godoy P; Minguell S; Ferrús G; Cabezas C; Domínguez Á; ; Spain
    Hum Vaccin Immunother; 2013 Mar; 9(3):675-80. PubMed ID: 23303107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
    Prymula R; Povey M; Brzostek J; Cabrnochova H; Chlibek R; Czajka H; Leviniene G; Man S; Neamtu M; Pazdiora P; Plesca D; Ruzkova R; Stefkovicova M; Usonis V; Verdanova D; Wysocki J; Casabona G; Habib MA
    Vaccine; 2021 May; 39(19):2643-2651. PubMed ID: 33858718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.